A new study by Turin et al. reports that proteinuria of increasing severity is associated with a faster rate of decline in estimated glomerular filtration rate (eGFR), regardless of eGFR at baseline. These findings support the use of proteinuria testing to identify individuals at risk of chronic kidney disease progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Turin, T. C. et al. Proteinuria and rate of change in kidney function in a community-based population. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2012111118.
Levey, A. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17–28 (2011).
Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Workgroup. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Suppl. 3, 1–150 (2013).
Iseki, K., Ikemiya, Y., Iseki, C. & Takishita, S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 63, 1468–1474 (2003).
Iseki, K. Evidence for asymptomatic microhematuria as a risk factor for the development of ESRD. Am. J. Kidney Dis. 60, 12–14 (2012).
Neugarten, J. et al. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 11, 319–329 (2000).
Nitsch, D. et al. Association of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ 346, f324 (2013).
Iseki, K. et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 49, 800–805 (1996).
Imai, E. et al. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens. Res. 31, 433–441 (2008).
Ruggnenti, P., Cravedi, P. & Remuzzi, G. Mechanisms and treatment of CKD. J. Am. Soc. Nephrol. 23, 1917–1928 (2012).
Acknowledgements
The author's work is supported, in part, by Health and Labour Sciences Research Grants for “Research on the positioning of chronic kidney disease (CKD) in Specific Health Check and Guidance in Japan” (20230601), a grant for strategic outcome study project for renal disease (H19-renal disease-senryaku-001), the Ministry of Health, Labour and Welfare of Japan.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Iseki, K. Proteinuria as a predictor of rapid eGFR decline. Nat Rev Nephrol 9, 570–571 (2013). https://doi.org/10.1038/nrneph.2013.177
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.177
This article is cited by
-
Epidemiology of dyslipidemia in chronic kidney disease
Clinical and Experimental Nephrology (2014)
